(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...

NEW YORK, June 27 (Reuters) - Two widely used diabetes medicines, Januvia and Byetta, pose no additional risk for cases of inflamed pancreas compared with other diabetes drugs, according to an ...

The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, which is used to treat blood cancers. The savings range from 79% for Januvia, used to manage diabetes, to 38% for ...

After years of battling over the patents on blockbuster diabetes drug Januvia, Merck and its generic rival Viatris are ready to put the case to rest. In a recent filing with the U.S. District Court ...

The cuts stem from the Inflation Reduction Act, not Trump’s “most favored nation” approach, and apply to what Medicare pays ...

Diabetics gained a new way of controlling their blood sugar levels Tuesday with the federal approval of a novel pill for Type 2 diabetes, which affects about 20 million Americans. The Food and Drug ...

The Biden administration on Tuesday tabbed 10 commonly used prescription drugs, including some that treat diabetes, for price negotiations with their manufacturers in a bid to put the brakes on rising ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has learned that some samples of sitagliptin, used to treat type 2 diabetes, may contain a ...

Do not use if you have ever had an allergic reaction to SITAGLIPTIN MYLAN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any ...